Antineoplastic Activity of Natural Products Novel Mechanistic Insights
Loading...
Date
item.page.authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Cancer is among the leading causes of death worldwide, with an estimated 9.6
newlinemillion deaths in the year 2018, according to the World Health Organization. Some of
newlinethe characteristics of cancer are unregulated proliferation, evasion of programmed cell
newlinedeath and metastasis. Natural Products have long been an abundant source of cure for
newlinemany diseases, including cancer, due to their vast structural diversity (1). Recently,
newlinethere has been a renewed interest in the Natural Product arena, as a source of potentially
newlinenovel compounds that can be pharmacologically active for cancer therapeutics. A large
newlinenumber of plants containing alkaloids, toxoids, flavonoids and podophyllotoxins
newlinepossess remarkable anticancer properties which need further development to become
newlinenew anticancer drugs (2 4). The coconut shell (endocarp) which is an underutilized
newlineagricultural waste from the plant Cocos nucifera has been utilized in many traditional
newlinemedicinal practices to cure several ailments, including skin infection and are mostly
newlinenon-toxic to humans (5,6). Since there are not many studies on the bioprospection of
newlinecoconut shell, it was an excellent candidate to be explored for its anticancer properties.
newlineThe degradation of the extracellular matrix by matrix metalloproteinases
newline(MMPs) is a crucial step in cancer progression. MMPs and Epidermal Growth Factor
newlineReceptors (EGFR) are up-regulated in practically all human cancers and mediate
newlineunregulated cell proliferation, migration, invasion, and metastasis (5 7). In addition to
newlineMMPs and EGFR, cyclooxygenase-2 (COX-2) and Vascular Endothelial Growth
newlineFactor (VEGF) play a substantial part in promoting various types of cancer (8,9). Hence
newlinetargeting these key markers can have a significant effect in regulating cancer. Many
newlineanti-cancer compounds also work by triggering programmed cell death via caspasexi
newlinedependent and caspase-independent pathways. Apoptosis, a caspase-mediated cell
newlinedeath pathway is one of the prominent targets of many chemotherapeutic agents.
newlineMutations of apoptosis-related genes...